VISEN Pharmaceuticals (HKG:2561)
Hong Kong
· Delayed Price · Currency is HKD
32.56
+1.06 (3.37%)
At close: Mar 10, 2026
VISEN Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -216.79 | -182.24 | -249.57 | -288.97 |
| Depreciation & Amortization | 2.46 | 3.95 | 6.15 | 6.67 |
| Other Amortization | 0.51 | 0.51 | 0.85 | 0.72 |
| Loss (Gain) From Sale of Assets | -0.72 | - | 0.24 | 0.09 |
| Stock-Based Compensation | 44.55 | 32.77 | -12.27 | 93.51 |
| Other Operating Activities | 3.08 | 2.48 | 67.12 | -0.77 |
| Change in Accounts Payable | -1.32 | 1.21 | -12.08 | 4.44 |
| Change in Unearned Revenue | - | -2.9 | - | - |
| Change in Other Net Operating Assets | -12.01 | 3.36 | -71.75 | -62.25 |
| Operating Cash Flow | -180.24 | -140.86 | -271.31 | -246.55 |
| Capital Expenditures | -0.12 | -0.12 | -0.52 | -1.48 |
| Sale (Purchase) of Intangibles | 9.24 | - | - | -0.28 |
| Investing Cash Flow | 9.12 | -0.12 | -0.52 | -1.77 |
| Long-Term Debt Repaid | - | -3.09 | -4.95 | -5.78 |
| Net Debt Issued (Repaid) | -2.31 | -3.09 | -4.95 | -5.78 |
| Other Financing Activities | -20.37 | - | -2.01 | -2.17 |
| Financing Cash Flow | 700.54 | -3.09 | -6.95 | -7.95 |
| Foreign Exchange Rate Adjustments | 0.17 | -0.13 | 0.11 | 0.07 |
| Net Cash Flow | 529.59 | -144.2 | -278.68 | -256.2 |
| Free Cash Flow | -180.36 | -140.98 | -271.83 | -248.03 |
| Free Cash Flow Margin | -21445.66% | -5076.52% | - | - |
| Free Cash Flow Per Share | -1.86 | -1.51 | -2.90 | - |
| Levered Free Cash Flow | - | -63.57 | -67.66 | - |
| Unlevered Free Cash Flow | - | -63.47 | -67.46 | - |
| Change in Working Capital | -13.33 | 1.66 | -83.83 | -57.81 |
Source: S&P Capital IQ. Standard template.
Financial Sources.